Precisely deliver toll-like receptor agonists using a dual-responsive nanovaccine for effective cancer immunotherapy
Yumeng Xing, Ruiying Wu, Zhaoyuan Tu, Meng Meng, Longwei Xiang, Huixin Li, Zongwei Shi, Guanhe Fang, Yuanji Feng, Ziqin Li, Huayu Tian, Xuesi Chen
Topics & Concepts
Dual (grammatical number)Cancer immunotherapyImmunotherapyToll-like receptorMaterials scienceTollCancer researchCancerReceptorMedicineImmunologyInternal medicineInnate immune systemLiteratureArtNanoplatforms for cancer theranosticsNanoparticle-Based Drug DeliveryImmunotherapy and Immune Responses